Amani Therapeutics secures $25 million Series A to advance AM-01, a therapy for serious neuropsychiatric disorders, with backing from RTW Investments.
Amount Raised
$25 Million
Round Type
Series A
Investors
Description
Amani Therapeutics, a biotechnology company, has closed a $25 million Series A financing. The funding will be used to advance AM-01, which aims to provide a safer treatment for serious neuropsychiatric disorders. This therapy includes a novel chemical entity licensed from AstraZeneca. Amani Therapeutics is focused on creating effective medicines for patients struggling with neuropsychiatric conditions.
Quick answer
Amani Therapeutics raised $25 Million in a Series A round, dated March 23, 2026. Investors: RTW Investments.
- How much did Amani Therapeutics raise?
- Amani Therapeutics raised $25 Million in a Series A round on March 23, 2026.
- Who invested in Amani Therapeutics?
- RTW Investments is named as investors in this round.
- What does Amani Therapeutics do?
- Amani Therapeutics is a biotechnology company dedicated to developing highly efficacious, safer medicines for people living with serious neuropsychiatric disorders.
- Where is Amani Therapeutics based and how big is it?
- Fundz records about 11 employees.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Amani Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Citius Oncology raised $37M on May 6, 2026.
- Remedium Bio raised $10M (Series A) on May 6, 2026.
- Windward Bio raised $165M (Funding Round) on May 5, 2026.
- Aura Biosciences, Inc. raised $238M (Post-IPO Equity) on May 4, 2026.
- Cue Biopharma raised $30M on May 4, 2026.
- mbiomics raised $35M (Series A) on April 29, 2026.
Who to call at Amani Therapeutics, and when
A new round usually means Amani Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Amani Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Amani Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Amani Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Amani Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansAmani Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.